Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →Some links on this page are affiliate links: if you buy through them we may earn a commission, at no extra cost to you.
Yes—AI is already changing medicine, but not in the way many headlines suggest. The U.S. Food and Drug Administration (FDA) says more than 1,600 AI-enabled medical devices were authorized for U.S. marketing by September 2026. Most are narrowly scoped image-analysis tools, especially for radiology, rather than autonomous doctors. AI is also appearing in drug discovery and development, where the FDA has received hundreds of submissions involving AI. The important qualification is that authorization confirms a device meets the requirements of its regulatory pathway for an intended use; it does not automatically prove better survival, fewer complications, or superior care for every population. Understanding what was authorized, how it was validated, and how it is updated is the difference between a useful medical tool and an overhyped claim.
What does “AI in medicine” actually include?
In medicine, AI generally means software that finds patterns in complex data and produces information used for detection, diagnosis, treatment, monitoring, or another defined healthcare task. The FDA regulates the medical device and its intended use, not “AI” as a separate product category. A machine-learning algorithm embedded in an imaging workstation, a clinical decision-support module, and software used during drug development can therefore face different regulatory questions.
As an Amazon Associate I earn from qualifying purchases.
Recommended Free Tools
The agency describes AI-enabled devices as systems that can analyze large and complex datasets, identify patterns, and generate information that may support disease detection, diagnosis, treatment, and other aspects of care. That definition covers both traditional machine-learning models and newer approaches, but it does not mean every healthcare product that uses the word “AI” is an FDA-authorized medical device. Intended use, risk, claims, and the device’s technology determine which rules apply.
This distinction matters to patients. A tool designed to flag a possible lung nodule for a radiologist is not the same as a system that recommends a treatment, controls a therapy, or communicates directly with a patient. The first may be an assessment aid; the latter can introduce additional safety, clinical, and human-factors risks.
Popular on Amazon
- Read Before You Buy — No Video Output: These adapters support charging and USB 2.0 data transfer, but cannot transmit video signals. Except for standard USB webcams (which use USB data only), they are not compatible with HDMI/DisplayPort cables, video-capable USB-C hubs, or docking stations with video output.
- Convert USB-A Ports to USB-C: Designed to connect USB-C earphones, cables, flash drives, card readers, and other USB-C accessories to standard USB-A ports. Plug-and-play with no drivers or software required.
- Aluminum Alloy Housing: Built with a sturdy aluminum alloy shell that aids in heat dissipation and protects against daily wear and scratches. Designed to maintain a stable and secure connection.
- Compact & Travel-Friendly: The ultra-compact design allows the adapter to stay plugged into your device without blocking adjacent ports or adding bulk, reducing wear and tear on your original USB ports.
- 12-Month Warranty: Backed by a 12-month manufacturer warranty for peace of mind. Designed to meet strict quality control standards for reliable everyday performance.
How many AI medical devices are authorized in the United States?
The FDA reported more than 1,600 AI-enabled medical devices authorized for U.S. marketing as of September 2026. That is the best current headline count, but it is not a permanent total: the agency’s searchable list changes as new devices are authorized, records are corrected, and products leave the market.
Earlier counts show how quickly the category expanded. The Stanford AI Index counted 139 FDA AI-related device approvals in 2022, more than 45 times the 2012 figure. In October 2023, that report said no FDA-authorized device was powered by generative AI or a large language model. Those historical observations cannot be substituted for the September 2026 count, because the regulatory inventory and the technology have continued to change.
“Authorized” is also broader than a single approval route. FDA marketing authorization can occur through 510(k) clearance, De Novo classification, or premarket approval, depending on the device’s risk and whether a suitable predicate exists. The pathway affects what evidence is required and what the authorization means.
Where is medical AI being used most?
Most authorized systems are specialized assessment tools that work on images. A taxonomy of 1,016 FDA authorizations through 2024 found that 84.4% used images as their core input and 84.1% served assessment functions. In other words, the current revolution is concentrated in software that helps a clinician interpret an existing test, not in software that independently manages an entire patient journey.
| Dimension | Finding from the 1,016-authorisation taxonomy | What it means |
|---|---|---|
| Input modality | 621 devices (84.4%) used images; 107 (14.5%) used signals; five (0.7%) used omics data; three (0.4%) used tabular electronic-health-record data | Imaging has the deepest regulatory footprint; other data types are much less represented in this dataset. |
| Primary function | Assessment: 84.1%; intervention: 15.9% | Most products analyze or classify information rather than deliver treatment themselves. |
| Review panel for imaging devices | Radiology was the lead panel for 88.2% | Radiology is the central beachhead for authorized medical AI. |
The categories overlap with ordinary clinical workflow. An image-analysis model may prioritize a scan for review, mark a suspicious region, quantify anatomy, or estimate a measurement. A clinician remains responsible for interpreting the result in context, checking the underlying image, and deciding what to do next unless the device’s labeling explicitly supports a different role.
What did FDA-authorized machine-learning devices look like in 2024?
A 2025 study in Biomedicines, indexed by PubMed, examined 168 Class II machine-learning devices authorized during 2024. It provides a useful snapshot of authorization practice, not a guarantee that every product delivered a patient benefit.
Also popular on Amazon
- 5-in-1 USB-C Hub: Experience comprehensive connectivity featuring a Power Delivery input, two USB-A 2.0 ports, a USB-A 3.0 port, and an HDMI port. (Note: The USB-C power delivery input port is only for connecting an external wall charger to power your laptop and cannot power peripheral devices.)
- 90W Pass-Through Charging: Achieve optimal charging with 90W pass-through power to your laptop, supported by a total input of 100W, with the hub reserving 10W for operational efficiency. (Note: Wall charger not included.)
- Quick Data Transfers: Accelerate your productivity with rapid data transfers using a high-speed 5Gbps USB 3.0 port and two 480Mbps USB 2.0 ports.
- 4K HDMI Display: Enhance your visual experience with a hub capable of delivering 4K resolution at 30Hz in both mirror and extend modes. Please note that this hub is compatible with MacBook (macOS 12 and newer), Windows 10 and 11, ChromeOS, and laptops equipped with DP Alt Mode and Power Delivery. Note: This device is not compatible with Linux.
- What You Get: Anker USB-C Hub (5-in-1, 4K HDMI), welcome guide, 18-month warranty, and our friendly customer service.
| Measure | 2024 cohort result | How to read it |
|---|---|---|
| Regulatory route | 159 devices (94.6%) used 510(k); nine (5.4%) used De Novo | The cohort was dominated by substantial-equivalence clearances rather than new classifications. |
| Clinical area | Radiology 74.4%; cardiovascular 6.5%; neurology 6.0% | Radiology remained the largest concentration by a wide margin. |
| Reporting both sensitivity and specificity | 49 devices (29.2%) | Most records did not report both measures in the way the study assessed. |
| Demographic data reported | 15.5% | Publicly visible information about performance across demographic groups was limited. |
| Predetermined change-control plan (PCCP) mentioned | 16.7% | Only a minority of records described a planned approach for specified future modifications. |
| Cybersecurity mentioned | 54.2% | Security disclosure was common but not universal in the examined records. |
These figures describe what authorization records and associated disclosures contained. They do not establish that a device improves mortality, morbidity, diagnostic delay, workload, or patient experience. They also do not show that an omitted metric was never measured; it may have been submitted in material that is not visible in the record analyzed by the study.
Does FDA clearance mean an AI tool works?
No. Clearance means the device met the requirements of its particular regulatory pathway for its labeled intended use; it is not a blanket finding of clinical superiority. A reader should separate four questions that are often collapsed into the word “works.”
- Analytical performance: Does the software process its input correctly under the conditions studied?
- Regulatory authorization: Did FDA reviewers find the evidence adequate for the selected pathway and intended use?
- Prospective clinical validation: Does performance hold when the tool is used forward in real clinical workflows, with the patients and equipment it will encounter?
- Patient-centered benefit: Does using the tool lead to better outcomes, safer decisions, faster appropriate treatment, or a better experience without unacceptable harms?
A high sensitivity value, for example, can be useful for a triage tool, but it may come with more false positives. Specificity, calibration, the prevalence of disease in the deployment setting, and the consequences of a missed or incorrectly flagged case all affect clinical value. A result generated on images from one scanner model or hospital population may not transfer unchanged to another setting.
FDA’s pathway also matters. The 510(k) route generally relies on substantial equivalence to a legally marketed predicate. De Novo is used for certain novel, low- to moderate-risk devices without a suitable predicate. Premarket approval is the most stringent route and is reserved for high-risk devices. None of these labels, by itself, answers whether a tool improves outcomes in every hospital or demographic group.
Can patients trust an AI diagnosis?
Patients should treat an AI output as evidence to be interpreted, not as a diagnosis that bypasses a qualified clinician. Trust should be proportional to the tool’s intended role, the quality of its validation, and the transparency of its limitations.
Questions a clinician or health system should answer
- What exact condition or finding is the system designed to detect?
- Is it a triage, notification, measurement, diagnostic-support, treatment-support, or monitoring tool?
- What data were used for validation, and were they independent of the training data?
- Are sensitivity, specificity, false-positive rates, and calibration reported for the population in which it will be used?
- Does performance vary by age, sex, race, ethnicity, pregnancy status, disability, scanner, language, or care setting?
- What is the clinician’s required response when the software disagrees with the image, laboratory result, or patient’s symptoms?
- How are errors, downtime, cybersecurity incidents, and model changes reported?
A patient can also ask whether a result was produced by an FDA-authorized device for that particular use or by a general-purpose consumer application. Authorization is tied to labeling and intended use; using software outside that scope changes the evidence and responsibility picture.
Also popular on Amazon
- Sleek 7-in-1 USB-C Hub: Features an HDMI port, two USB-A 3.0 ports, and a USB-C data port, each providing 5Gbps transfer speeds. It also includes a USB-C PD input port for charging up to 100W and dual SD and TF card slots, all in a compact design.
- Flawless 4K@60Hz Video with HDMI: Delivers exceptional clarity and smoothness with its 4K@60Hz HDMI port, making it ideal for high-definition presentations and entertainment. (Note: Only the HDMI port supports video projection; the USB-C port is for data transfer only.)
- Double Up on Efficiency: The two USB-A 3.0 ports and a USB-C port support a fast 5Gbps data rate, significantly boosting your transfer speeds and improving productivity.
- Fast and Reliable 85W Charging: Offers high-capacity, speedy charging for laptops up to 85W, so you spend less time tethered to an outlet and more time being productive.
- What You Get: Anker USB-C Hub (7-in-1), welcome guide, 18-month warranty, and our friendly customer service.
Why do demographic reporting and external validation matter?
Medical datasets are not interchangeable. Disease prevalence, image quality, referral patterns, treatment practices, and population characteristics can differ from the data used to develop a model. If a model sees fewer examples of a subgroup, its error rate or calibration may differ even when its overall average looks strong.
The 2024 cohort study found demographic data in only 15.5% of the devices it examined. That does not prove that the other devices performed poorly across groups, but it makes independent assessment harder. A responsible procurement review should request subgroup results, confidence intervals where available, and an explanation of missing or underrepresented populations.
External validation should occur on data separated by time, site, equipment, or population from the development set. Prospective evaluation is stronger still because it captures workflow effects: alert fatigue, delays caused by extra verification, changes in clinician behavior, and the consequences of false reassurance.
What cybersecurity and privacy risks accompany medical AI?
AI systems inherit ordinary health-technology risks and add model-specific ones. A compromised image archive, interface, or cloud service can expose protected health information. An attacker who alters inputs may try to change a model’s output. Poorly controlled access can reveal training data or allow unauthorized model updates.
Cybersecurity was mentioned for 54.2% of the 2024 devices studied, so the issue is visible in many records but not universal. Before deployment, a health system should verify encryption, identity and access controls, audit logs, vulnerability disclosure, backup and downtime procedures, software-bill-of-materials practices where provided, and the process for emergency patches.
Privacy questions extend beyond storage. Organizations should know what information leaves the clinical environment, how long it is retained, whether it is used to improve the model, and which vendors or subcontractors can access it. Patients may need a clear explanation when their data are used for development or quality monitoring, subject to applicable law and institutional policy.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Also popular on Amazon
- Dual Converters, Infinite Potential：Includes 2× USB C male to USB A female adapters and 2× USB A male to USB C female adapters. Perfect for a wide range of uses—tablets with Bluetooth keyboards, expand USB ports on macbook, and more. Two different converters for all your daily needs
- Next-Level 10Gbps & 3A Charging: No more slow 480Mbps, this usb to usb c adapter has a transfer speed of up to 10Gbps, allowing you to do more transferring in less time. This usb adapter fits both USB A and USB C charger, supporting up to 3A fast charging
- Upgraded Exquisite Craftsmanship: With an aluminum alloy housing and metal connector, the usbc to usb adapter is extremely durable and sturdy. Rigorously tested to withstand more than 10,000 times of plugging and unplugging, ensuring long-lasting performance
- Widely Compatible: Transform any USB-C port into a USB-A port and USB-A port into a USB-C port, and connect up a wide range of USB-C(including MacBook, iPad Pro/Air/Mini, iPhone models with USB C ports, Samsung Galaxy series, and Google Pixel series. ) and USB A devices(including external hard drives, phones, mice, printers, and more)
- Please Note: To reach 10Gbps speed, keep the cable under 3.3 ft. For USB A Male to USB C adapters, try flipping the USB C connector. USB C Male to USB A adapters support bidirectional 10Gbps transfer within 3.3 ft
Is AI being used to discover and develop drugs?
Yes. AI is already part of drug discovery and development, although its role is different from that of an image-analysis device. An FDA perspective published in 2025 reported almost 1,000 AI-enabled medical devices and said the agency had received hundreds of regulatory submissions for drugs that used AI in discovery or development.
Drug-development applications can include identifying or ranking candidate molecules, predicting properties, selecting trial participants, analyzing clinical data, supporting manufacturing, and assisting regulatory decision-making. The algorithm does not replace the requirement to demonstrate a drug’s quality, safety, and efficacy. AI-generated hypotheses still have to survive laboratory, manufacturing, and clinical scrutiny.
FDA’s Center for Drug Evaluation and Research lists international guiding principles and guidance covering AI in drug and biological-product development, regulatory decision support, manufacturing, and related activities. Sponsors should document the model’s purpose, data provenance, validation, human oversight, change management, and the effect of errors on the resulting decision.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.How does FDA handle AI model updates after authorization?
AI software can change after launch as developers correct defects, improve performance, adapt to new data, or update connected components. An update that changes the model’s behavior can alter safety and effectiveness, even when the user interface looks identical.
Do these 3 things before closing this tab:
1Repair Windows errors before they cause bigger problems2Scan for outdated or missing drivers - takes under a minute3Clear out junk files and repair common Windows errorsFDA’s 2024 final guidance on predetermined change-control plans (PCCPs) explains how planned modifications to AI-enabled software can be described in a marketing submission. A PCCP can set out the types of changes anticipated, the methods used to implement and validate them, and the assessment required before release. The guidance emphasizes continued safe and effective operation, including for diverse populations.
For buyers, a PCCP is not a promise that a model will improve forever. It is a governance mechanism. Ask which changes are covered, what evidence triggers a rollback, who approves deployment, how versions are logged, and whether a change requires a new regulatory submission. Continuous performance monitoring should include drift detection, subgroup checks, incident review, and a way to suspend the system if its outputs become unreliable.
Also popular on Amazon
- 5-in-1 Connectivity: Equipped with a 4K HDMI port, a 5 Gbps USB-C data port, two 5 Gbps USB-A ports, and a USB C 100W PD-IN port. Note: The USB C 100W PD-IN port supports only charging and does not support data transfer devices such as headphones or speakers.
- Powerful Pass-Through Charging: Supports up to 85W pass-through charging so you can power up your laptop while you use the hub. Note: Pass-through charging requires a charger (not included). Note: To achieve full power for iPad, we recommend using a 45W wall charger.
- Transfer Files in Seconds: Move files to and from your laptop at speeds of up to 5 Gbps via the USB-C and USB-A data ports. Note: The USB C 5Gbps Data port does not support video output.
- HD Display: Connect to the HDMI port to stream or mirror content to an external monitor in resolutions of up to 4K@30Hz. Note: The USB-C ports do not support video output.
- What You Get: Anker 332 USB-C Hub (5-in-1), welcome guide, our worry-free 18-month warranty, and friendly customer service.
How should a hospital compare two medical-AI tools?
Compare the tools on their clinical job and evidence, not on an impressive demo or a generic accuracy percentage. The following sequence keeps procurement focused on patient risk.
- Define the decision: Write the exact clinical action the software is expected to support and what happens when it is wrong.
- Check the input: Identify whether it uses images, physiologic signals, omics data, electronic-health-record fields, or a combination, and confirm that local systems can supply those inputs reliably.
- Verify the regulatory status: Read the device’s intended-use statement, pathway, indications, contraindications, and predicate information rather than relying on a marketing category.
- Inspect performance: Request sensitivity, specificity, calibration, confidence intervals, prevalence assumptions, and subgroup results. Ask whether validation was external and prospective.
- Model workflow effects: Estimate alert volume, turnaround time, integration with the image archive or record, escalation rules, training needs, and the human review required.
- Review resilience: Examine cybersecurity controls, data retention, downtime behavior, auditability, and incident response.
- Govern updates: Obtain the change-control plan, version policy, monitoring dashboard, rollback process, and responsibilities for post-market reporting.
- Measure outcomes locally: Predefine measures such as time to appropriate treatment, unnecessary follow-up, missed findings, equity indicators, and patient experience. Authorization does not supply these local results.
What is the most realistic outlook for medical AI?
The evidence points to an infrastructure layer growing inside existing medical systems, not to a sudden replacement of clinicians. Imaging will remain a major entry point because digital images are abundant, structured, and compatible with assessment workflows. Drug development will broaden as regulators gain experience with models that influence research, manufacturing, and submissions.
Free tools Windows power users keep installed
One-click scans. No signup required.
The harder work is proving durable benefit. Authorization counts can rise faster than transparent demographic reporting, independent validation, and patient-centered outcome studies. Hospitals and patients should therefore judge each tool by its defined use, evidence quality, update controls, and observed effect on care—not by the presence of the AI label or the size of the authorization list.
Frequently Asked Questions
Can an AI medical device make a final diagnosis without a doctor?
Most authorized systems are labeled to support assessment or workflow, leaving a qualified professional to interpret the result and act on it. Whether any particular device can operate with less direct oversight depends on its FDA-cleared or approved intended use and labeling; a general AI chatbot has no such medical-device authorization merely because it can discuss symptoms.
Why might an AI tool perform differently at two hospitals?
The hospitals may use different scanners, protocols, patient populations, referral thresholds, or electronic interfaces. Those differences can shift disease prevalence and image quality, so a model’s calibration and false-positive rate should be checked locally rather than copied from another site.
What should happen if a clinician disagrees with an AI result?
The clinical team should follow the device’s labeling and the institution’s escalation policy, recheck the underlying data, and document the disagreement when appropriate. A model output is an aid; it does not override symptoms, examination findings, or other validated tests unless the approved workflow explicitly says otherwise.
Does generative AI have FDA approval for medical advice?
There is no single FDA approval that covers “generative AI for medical advice.” Authorization is granted to a specific device for a specific intended use, and a general-purpose language model may fall outside medical-device labeling even when a clinic uses it in practice.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
